Shareholders appeared unconcerned with DuPont de Nemours, Inc.'s ( NYSE:DD ) lackluster earnings report last week.
Nemours Children’s offers one of two DBT programs in Delaware, providing teens with support, validation, and skills to ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Hosted on MSN7d
Patient from Nemours Children's Hospital talks about being part of the U.S. Paralympics SwimmingTalk about bravery and determination. A patient from Nemours Children’s Hospital takes part in the U.S. Paralympics Swimming ...
Aubrey Whelan and Alison McCook, Inquirer health reporters, @aubreyjwhelan @alisonmccook The Big Read: An unprecedented TB ...
A patient from Nemours Children's Hospital in Delaware was part of the U.S. Paralympics Swimming National Championships.
Van ECK Associates Corp grew its holdings in DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 0.6% in the third quarter, ...
EPS: US$1.13 (up from US$0.62 in 3Q 2023). Looking ahead, revenue is forecast to grow 5.5% p.a. on average during the next 3 ...
Jefferies analyst Laurence Alexander maintained a Buy rating on DuPont de Nemours (DD – Research Report) yesterday and set a price target of $101.00. Laurence Alexander has given his Buy rating due to ...
Bank of America Securities analyst Steve Byrne maintained a Sell rating on DuPont de Nemours (DD – Research Report) today and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback